SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for XOMA Royalty Corp (CIK 0000791908) (XOMA) — Sep 7, 2016

XOMA Royalty Corp (CIK 0000791908)
Date: Sept. 7, 2016 · CIK: 0000791908 · Accession: 0000000000-16-091719

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
September 7, 2016
Author
/s/ Erin K. Jaskot, for
Form
UPLOAD
Company
XOMA Royalty Corp (CIK 0000791908)

Letter

Mail Stop 4 546 September 7, 2016 John Varian Chief Executive Officer XOMA Corporation 2910 Seventh Street Berkeley, California 94710

Re: XOMA Corporation Preliminary Proxy Statement on Schedule 14A Filed September 2, 2016 File No. 000 -14710

Dear Mr. Varian :

We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Erin K. Jaskot, for

Show Raw Text
Mail Stop 4 546
September 7, 2016

John Varian
Chief Executive Officer
XOMA Corporation
2910 Seventh Street
Berkeley,  California 94710

Re: XOMA Corporation
 Preliminary Proxy Statement on Schedule 14A
Filed September 2, 2016
File No. 000 -14710

Dear Mr. Varian :

We have completed our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Erin K. Jaskot, for

Suzanne Hayes
Assistant Director
Office of Healthcare and Insurance